Theravance Biopharma, Inc. | TalkMarkets | Page 1

Theravance Biopharma, Inc. | TalkMarkets | Page 1

Sign Up
Sign up with:

People who follow this stock (36)

View All

Latest Posts

About This Stock More About This Stock

Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal

Article By: ChinaBio® Today

Saturday, November 18, 2023 2:00 PM EDT

Legend Biotech partnered its DLL3 CAR-T candidates to Novartis in a $1.2 billion agreement, with $100 million offered upfront. Novartis will own worldwide rights to develop, manufacture, and commercialize the DLL3 group of cell therapies.

In this article: NVS, TBPH, LEGN, VTRS, APLM Also: WXXWY

Wednesday Global Investing Report

Article By: Vivian Lewis

Wednesday, December 8, 2021 7:56 PM EDT

Between the Amazon Cloud issues and the clouds gathering over the Ukraine border, it's getting harder to tell exactly what's happening to markets. Here are some insights into the international companies in our portfolio.

In this article: CVE, GSK, MRK, NVO, PFE, VE, RHHBY, SSNLF, SZEVF, TMRAF, MELI, TSEM, MRNA, TBPH, KL, BNTX

Monday Markets Unhinged

Article By: Vivian Lewis

Monday, May 3, 2021 4:54 PM EDT

Today's stock market is somewhat unhinged because so many foreign markets are shut for a bank holiday: Britain, China, Thailand, Japan.

In this article: CCJ, KL, AZRE, NIO, ESPR, TBPH, ZYME, AQN, AY, BHC, TAK, TEVA, OCGN

Theravance Biopharma - Chart Of The Day

Article By: Jim Van Meerten

Tuesday, September 20, 2016 8:22 PM EDT

Since the Trend spotter signaled a buy on 7/27 the sock gained 45.37%.

In this article: TBPH

Theravance Bio - Sell Signals

Article By: Jim Van Meerten

Tuesday, May 10, 2016 10:45 PM EDT

I recently deleted Theravance Bio from the Barchart Van Meerten New High portfolio for negative price momentum.

In this article: TBPH